OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert Novo.../  DE000ME6E786  /

Stuttgart
2024-06-14  8:33:23 PM Chg.+0.28 Bid10:00:34 PM Ask10:00:34 PM Underlying Strike price Expiration date Option type
58.53EUR +0.48% -
Bid Size: -		 -
Ask Size: -		 - - DKK 2024-12-31 Call
TeleTrader 06-15 Novo Nordisk CEO to voluntarily testify before US committee
GlobeNewswire 06-14 Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
GlobeNewswire 06-13 Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire 06-13 Biosplice Announces Collaboration with Novo Nordisk in Diabetes
GlobeNewswire 06-11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 06-10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 06-10 Veru to Present at the American Diabetes Association's 84th Scientific Sessions
GlobeNewswire 06-03 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 06-03 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 05-31 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 05-22 Veru to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 05-15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire 05-15 Aeterna Zentaris Reports First Quarter 2024 Financial Results
GlobeNewswire 05-14 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Sci...
GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 05-07 Vect-Horus to Take Part in a Roundtable Discussion at Viva Technology Conference
TeleTrader 04-25 Europe opens mostly down after corporate earnings
GlobeNewswire 04-22 Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to...
GlobeNewswire 04-22 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 04-22 SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into cli...
GlobeNewswire 04-11 Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings
GlobeNewswire 04-02 Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting C...
GlobeNewswire 04-02 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
GlobeNewswire 03-28 Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategi...